Background
==========

Foodborne illnesses continue to be an important public health concern in developing, as well as in developed countries, thus prevention of foodborne illness outbreaks through effective and novel interventions should be given priority. The U.S. Public Health Service has identified ten important foodborne pathogens causing human illnesses, including pathogenic strains of *Escherichia coli*, *Salmonella*, *Listeria, Clostridium botulinum*, *Shigella*, and *Campylobacter*, which are associated with more than 250 known foodborne diseases (<http://www3.niaid.nih.gov/topics/foodborne/default.htm>).

In addition, according to the World Health Organization (WHO), antibiotic overuse in food animal production is a major contributor to the emergence of antibiotic resistant foodborne pathogens \[[@B1]\]. The use of antibiotics in food animals for growth promotion and treatment disrupts the normal beneficial commensal bacterial microflora in the animal intestinal tract \[[@B2]-[@B6]\]. Recently, the human and chicken gut microbiome projects \[[@B7]-[@B12]\] have shed new light on the existence of a bacterial 'phylogenetic core' \[[@B13]\] consisting of a wide diversity of gastrointestinal bacteria by using new technologies such as next generation sequencing, 16S rRNA screens, metagenomics, and metaproteomics. Healthful, commensal bacteria found in the GI tract might be key members of known or potential probiotic strains revealed in this 'phylogenetic core', which may include *Bacillus clausii, Bacillus pumilus*, *Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus rhamnosus GG* (ATCC 53103), *Bifidobacterium infantis, Saccharomyces boulardii*, *Lactobacillus ruminis*, *Lactobacillus johnsonii* str. NCC 533, and many others. These known probiotic strains have been used as dietary supplements, as treatments for illnesses caused by foodborne pathogens, and for disease prevention. Use of probiotic strains not only reduce invasion by bacterial pathogens, but also restore and maintain an optimal balance of healthy commensal bacteria in the human gut via production of antimicrobials \[[@B14]-[@B23]\].

One of the major mechanisms recognized as being responsible for apoptosis, or programmed cell death, and production of toxic metabolites in bacteria is through the regulation of a wide variety of bacterial toxin-antitoxin modules \[[@B24]-[@B26]\], such as MazE/MazF, a chromosomal toxin-antitoxin module \[[@B27]-[@B30]\], plasmid-encoded *par*D \[[@B31]-[@B33]\], *chpBIK*\[[@B26],[@B34]\], *relBE*\[[@B35],[@B36]\], and the PhoQ-PhoP system \[[@B37]-[@B40]\]. MazEF is one of the most well-studied toxin--antitoxin (TA) systems and has been found on the chromosomes of many bacteria. The MazF protein has been recently categorized as an endoribonuclease \[[@B41],[@B42]\] or as a type of RNA interference enzyme \[[@B43]\]. The link between this TA system and quorum sensing has also been explored recently through a small pentapeptide (NNWNN) called the Extracellular Death Factor (EDF) \[[@B44]\]. This small peptide motif (such as NNWNN) is known to be an extra-cellular death factor in *E. coli* and other bacterial species. The necessity of an "extracellular death factor" (EDF) or "cell death factor" (CDF) via MazEF-mediated cell death is a population phenomenon requiring the activation of quorum-sensing (cell-to-cell signaling) peptides in bacteria. High cell density was found to be associated with elevated concentrations of EDF, and the presence of EDF resulted in MazF-induced cell death \[[@B44]\]. From a food safety and public health perspective, use of EDF or a similar strategy may be used in place of antibiotics, resulting in less usage of antibiotics. We also noticed in one very interesting study that the induction of toxin MazF and the use of antibiotic share a similar mechanism by inhibiting the transcription and/or translation of the MazE antitoxin \[[@B45]\].

It has been theorized that there is "one toxin for one antitoxin" and interestingly MazF, in some bacteria, exhibits a selective inhibition of ribosomes and mRNAs \[[@B43],[@B46]\]. Numerous strains of probiotic bacteria, such as *Lactobacillus* spp., have been reported to produce antimicrobial agents \[[@B47]\], such as bacteriocins, that inhibit or kill closely-related species, or even different strains of the same species through the inhibition of transcription and translation by receptor binding. The antimicrobial activities of bacteriocins are due to a heterologous subgroup of ribosomally synthesized cationic peptides \[[@B48]\]. Nisin, a polycyclic antibacterial peptide 34 amino acid residues long, is one of the most studied bacteriocins and is produced by many strains of *Lactococcus lactis*. It has been approved by the FDA for use as a food preservative, and certain probiotic *Lactobacillus* strains have been thoroughly studied and evaluated *in vitro* and *in vivo*. For example*, L. reuteri* controls diarrhea in children and suppresses the growth and pathogenicity of harmful foodborne pathogens such as *Salmonella, E. coli*, *Staphylococcus*, and *Listeria*\[[@B49],[@B50]\]. *L. casei* GG has been used to treat *Clostridium difficile* infections and to reduce intestinal permeability \[[@B51]-[@B54]\]. *L. reuteri* is known to produce a broad-spectrum antimicrobial agent, reuterin, composed of the natural metabolic compound 3-hydroxypropionaldehyde, which has been used on the surface of sausages to inhibit growth of harmful bacteria and fungi \[[@B15],[@B16]\]. However, the molecular mechanisms underlying the effectiveness of individual probiotic strains have not been systematically studied and characterized. Several potential mechanisms of action, including their ability to generate diverse natural toxic metabolites, lactic acid, and other organic acids, enzymes, vitamins, and hydrogen peroxide, as well as antimicrobial peptides such as nisin, have been well-described \[[@B20]\].

The work reported herein explores the experimental antimicrobial possibilities and/or procedures for (1) expression of an engineered, stress-induced recombinant secreted fusion gene encoded by MazF and a small extracellular cell death factor (CDF) on the surface or extracellular space of recombinant probiotic bacteria or (2) for potential application of a cocktail of natural probiotic strains via experimental *in vitro* selection to control foodborne pathogens for improving the safety and quality of foods, as well as improving human health. The use of engineered probiotic strains or the natural probiotic cocktail consisting of mixed probiotic strain populations for targeting foodborne pathogens will potentially be able to selectively inactivate these pathogens, even in complex food matrices. Through gene/motif reshuffling \[[@B55],[@B56]\] and computational molecular modeling, this engineered and secreted bacterial fusion protein, MazF-CDF, which contains an enterokinase (EK) cleavage site \[[@B57]-[@B60]\] for releasing active CDF and MazF after protein secretion, should have a narrow range of applicability, limited to inactivating only specific foodborne pathogens such as *E. coli* O157, *Salmonella, Listeria*, *Campylobacter,* and potentially other human pathogens*.* This pathogen specificity is due to the fact that the genetically-engineered MazF-CDF fusion protein could be modified by the inclusion of specific genomic DNA sequences from various commensal, as well as pathogenic bacterial strains, identified through DNA/protein structure and functional comparisons. Additionally, this engineered antimicrobial polypeptide and MazF will be non-toxic to beneficial (healthful/probiotic) bacteria, as well as to its host that expresses the protein/peptide. Moreover, these engineered and secreted CDFs and MazF proteins/peptides can easily pass through infectious foodborne pathogen cell barriers mediating cell death, and thus could potentially reduce the use of deleterious compounds such as antibiotics or other harmful chemicals in the feed and food industry.

Results and discussion
======================

General genetic analysis of probiotics and foodborne pathogen genomes
---------------------------------------------------------------------

The genomic information from selected probiotic strains and foodborne pathogens is shown in Table [1](#T1){ref-type="table"}. It revealed little diversity in genomic GC-content in the *Bifidobacterium* genus, while showing an astonishing diversity in the GC-content among *Lactobacillus* species, ranging from 33 to 51.5%. It has been demonstrated that genomic GC-content is correlated with a number of factors \[[@B61]\], including genome size \[[@B62]\] from species such as *Lactobacillus*, which ranges from 1.8 to 3.4 Mb in length. This demonstrates that the GC-content and genome size of *Lactobacillus* genomes may have implications related to the biological complexity and adaptation of this genus, and could be due to the rate of recombination that has been extensively studied in the *E. coli* genome \[[@B63]\]. Knowledge of genetic diversity is fundamental to development of synthetic probiotic genomes and/or nucleic acid sequence reshuffling strategies. In this paper, we demonstrate that the MazF protein is a suitable candidate for the determination of genetic relationships within sets of MazF proteins in combination with with functional motif analysis.

###### 

Genomic information of selected microorganisms considered as potential probiotic strains and some major food-borne pathogens used in this study

  **Organism**                                          **Strain**       **Pathotype /or others**   **GenBank Accession /Assembly**   **GC (%)**   **Genome Size (\~ Mb)**
  ----------------------------------------------------- ---------------- -------------------------- --------------------------------- ------------ -------------------------
  *Campylobacter upsaliensis*                           JV21             pathogenic                 ASM18534v1                        NA           1.6
  *Lactobacillus coleohominis*                          101-4-CHN        probiotic                  ASM16193v1                        41.3         1.7
  *Campylobacter jejuni*                                RM1221           pathogenic                 NC_003912.7                       30.3         1.8
  *Lactobacillus johnsonii*                             FI9785           probiotic                  NC_013504.1                       34.4         1.8
  *Pediococcus pentosaceus*                             ATCC 25745       probiotic                  CP000422.1                        37.4         1.8
  *Streptococcus thermophilus* LMG                      LMG 18311        probiotic                  NC_006448.1                       39.1         1.8
  *Lactobacillus gasseri*                               ATCC 33323       probiotic                  NC_008530.1                       35.3         1.9
  *Lactobacillus sakei subsp. sakei*                    23K              probiotic                  NC_007576.1                       41.3         1.9
  *Lactobacillus delbrueckii subsp. bulgaricus*         ATCC 11842       probiotic                  NC_008054.1                       49.7         1.9
  *Lactobacillus delbrueckii subsp. bulgaricus*         ATCC BAA-365     probiotic                  NC_008529.1                       49.7         1.9
  *Leuconostoc citreum*                                 KM20             probiotic                  ASM2640v1                         38.9         1.9
  *Bifidobacterium animalis subsp. Lactis*              Bl-04            probiotic                  NC_012814.1                       60.5         1.9
  *Bifidobacterium animalis subsp. Lactis*              DSM 10140        probiotic                  NC_012815.1                       60.5         1.9
  *Bifidobacterium animalis subsp. Lactis*              AD011            probiotic                  NC_011835.1                       60.5         1.9
  *Lactobacillus amylovorus*                            GRL1118          probiotics                 ASM19411v1                        38.0         2.0
  *Lactobacillus johnsonii*                             NCC 533          probiotic                  NC_005362.1                       34.6         2.0
  *Lactobacillus acidophilus*                           NCFM             probiotic                  NC_006814.3                       34.7         2.0
  *Lactobacillus reuteri*                               DSM 20016        probiotic                  NC_009513.1                       38.9         2.0
  *Lactobacillus reuteri*                               JCM 1112         probiotic                  NC_010609.1                       38.9         2.0
  *Listeria monocytogenes*                              FSL J1-208       pathogenic                 ASM16843v1                        37.7         2.0
  *Lactobacillus salivarius*                            UCC118           probiotic                  NC_007929.1                       33           2.1
  *Lactobacillus helveticus*                            DPC 4571         probiotic                  NC_010080.1                       37.1         2.1
  *Leuconostoc mesenteroides subsp. mesenteroides*      ATCC 8293        probiotic                  NC_008531.1                       37.7         2.1
  *Campylobacter concisus*                              13826            pathogenic                 NC_009802.1                       39.3         2.1
  *Lactobacillus fermentum*                             IFO 3956         probiotic                  NC_010610.1                       51.5         2.1
  *Bifidobacterium adolescentis*                        ATCC 15703       probiotic                  NC_008618.1                       59.2         2.1
  *Bifidobacterium bifidum*                             PRL2010          probiotic                  NC_014638.1                       Na           2.2
  *Bifidobacterium bifidum*                             S17              probiotic                  NC_014616.1                       Na           2.2
  *Lactobacillus amylovorus*                            GRL 1112         probiotic                  NC_014724.1                       Na           2.2
  *Lactobacillus brevis*                                ATCC 367         probiotic                  NC_008497.1                       46.1         2.3
  *Lactobacillus crispatus*                             CTV-05           probiotic                  ASM16588v1                        37.1         2.3
  *Bifidobacterium longum*                              NCC2705          probiotic                  NC_004307.2                       60.1         2.3
  *Bifidobacterium longum subsp. longum*                BBMN68           probiotic                  NC_014656.1                       Na           2.3
  *Bifidobacterium longum subsp. infantis*              157F             probiotic                  NC_015052.1                       Na           2.4
  *Bifidobacterium longum subsp. longum*                JCM 1217         probiotic                  NC_015067.1                       Na           2.4
  *Lactococcus lactis subsp. lactis*                    Il1403           probiotic                  NC_002662.1                       35.3         2.4
  *Bifidobacterium longum*                              DJO10A           probiotic                  NC_010816.1                       60.2         2.4
  *Bifidobacterium longum subsp. longum*                JDM301           probiotic                  NC_014169.1                       Na           2.5
  *Lactococcus lactis subsp. cremoris*                  MG1363           probiotic                  NC_009004.1                       35.7         2.5
  *Listeria grayi*                                      DSM 20601        pathogenic                 ASM14899v1\*                      41.6         2.6
  *Propionibacterium freudenreichii subsp. shermanii*   CIRM-BIA1        probiotic                  NC_014215.1                       Na           2.6
  *Lactococcus lactis subsp. lactis*                    KF147            probiotic                  NC_013656.1                       34.9         2.6
  *Lactococcus lactis subsp. cremoris*                  SK11             probiotic                  NC_008527.1                       35.8         2.6
  *Bifidobacterium dentium*                             Bd1              probiotic                  NC_013714.1                       58.5         2.6
  *Bifidobacterium longum subsp. infantis*              ATCC 15697       probiotic                  NC_011593.1                       59.9         2.8
  *Listeria monocytogenes*                              EGD-e            pathogenic                 NC_003210.1                       38           2.9
  *Lactobacillus casei str.*                            Zhang            probiotic                  NC_014334.1                       40.1         2.9
  *Lactobacillus casei*                                 ATCC 334         probiotic                  NC_008526.1                       46.6         2.9
  *Lactobacillus paracasei subsp. paracasei*            ATCC 25302       probiotic                  ASM15949v1                        46.5         2.9
  *Lactobacillus rhamnosus*                             GG               probiotic                  NC_013198.1                       46.7         3.0
  *Lactobacillus rhamnosus*                             Lc 705           probiotic                  NC_013199.1                       46.7         3.0
  *Lactobacillus casei*                                 BL23             probiotic                  NC_010999.1                       46.3         3.1
  *Lactobacillus plantarum*                             JDM1             probiotic                  NC_012984.1                       44.7         3.2
  *Enterococcus faecalis*                               V583             probiotic                  NC_004668.1                       37.4         3.3
  *Lactobacillus plantarum*                             WCFS1            probiotic                  NC_004567.1                       44.4         3.3
  *Lactobacillus plantarum subsp. plantarum*            ST-III           probiotic                  NC_014554.1                       Na           3.4
  *Bacillus selenitireducens*                           MLS10            Bio agent                  ASM9308v1                         48.7         3.6
  *Bacillus pumilus*                                    SAFR-032         probiotic                  NC_009848.1                       41.3         3.7
  *Coprobacillus sp.*                                   29_1             Non-pathogenic             Coprobacillus_sp_29_1\_V1         NA           3.8
  *Vibrio cholerae*                                     M66-2            pathogenic                 NC_012578.1                       47.6         3.9
  *Bacillus halodurans*                                 C-125            Non-pathogenic             ASM1114v1                         43.7         4.2
  *Bacillus amyloliquefaciens*                          Y2               probiotic                  ASM28439v1                        45.9         4.2
  *Clostridium difficile*                               630              pathogenic                 NC_009089.1                       29.1         4.3
  *Bacillus clausii*                                    KSM-K16          probiotic                  NC_006582.1                       44.8         4.3
  *Shigella dysenteriae*                                Sd197            pathogenic                 ASM1200v1\]                       50.9         4.6
  *Shigella flexneri*                                   8401             pathogenic                 NC_008258.1                       50.9         4.6
  *Salmonella enterica subsp. arizonae serovar*         RSK2980          pathogenic                 NC_010067.1                       51.4         4.6
  *Enterobacter sp.*                                    638              pathogenic                 NC_009436.1                       52.9         4.7
  *Vibrio vulnificus*                                   CMCP6            pathogenic                 NC_004459.2                       46.7         5.1
  *Escherichia coli*                                    E24377A          pathogenic                 NC_009801.1                       50.6         5.2
  *Citrobacter rodentium*                               ICC168           pathogenic                 NC_013716.1                       54.6         5.4
  *Klebsiella variicola*                                At-22            pathogenic                 NC_013850.1                       57.6         5.5
  *Bacillus megaterium*                                 QM B1551         probiotic                  ASM2582v1                         38.0         5.5
  *Escherichia coli* O157:H7                            Sakai            pathogenic                 NC_002695.1                       50.5         5.6
  *Bacillus thuringiensis serovar israelensis*          ATCC 35646       Bio agents                 ASM16769v1                        35.0         5.9
  *Lachnospiraceae bacterium*                           3_1\_57FAA_CT1   Non-pathogenic             Lach_bact_3\_1_57FAA_CT1_V1       NA           7.7

\*: assembly accession.

Ubiquitous existence of MazE/toxin, MazF
----------------------------------------

MazEF is a toxin-antitoxin (TA) module widely distributed among many bacterial species, including both foodborne pathogens and probiotic strains (Table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}), such as *Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus rhamnosus GG* (ATCC 53103), *Escherichia coli, Selenomonas sputigena, Enterobacter* spp.*, Campylobacter* spp.*, Citrobacter* spp.*, Thermoanaerobacter tengcongensis, Pelotomaculum thermopropionicum, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus buchneri, Bifidobacterium longum subsp. infantis, Clostridium botulinum, Clostridium difficile, Vibrio* spp.*, Listeria* spp.*, Bacillus* spp.*, Klebsiella variicola, and Salmonella enterica.* Recent literature and computational analyses have shown the presence of many different types of TA modules in various localizations, e.g. some TA modules have been found within prophages, prophage-like elements, and other mobile genetic elements, such as plasmids \[[@B31]-[@B33]\]. Due to the existence of varying types of toxin-antitoxin modules and possible gene duplication events, in this paper we present the above one-to-one best matches of chromosomal-encoded *mazF* orthologs and homologs among 75 publically available genome sequences of foodborne pathogens and probiotic strains (Table [1](#T1){ref-type="table"}), and the publically-available databases such as NCBI and the Uniprot database (<http://www.uniprot.org/>) in Table [2](#T2){ref-type="table"}.

###### 

**The genetic characterization of the transcriptional modulator*MazF*, a chromosomal cell death factor from potential probiotic strains and some major food-borne pathogens used in this study**

  **Organism**                                       **Type of organisms**   **Strains**      **Protein accession (GenBank)**   **Gene annotation**
  -------------------------------------------------- ----------------------- ---------------- --------------------------------- ----------------------------------------------------------------------
  *E. coli*                                          Pathogen                EDL933           NP_289336.1                       toxin ChpA
                                                     Pathogen                Sakai            NP_311669.1                        
                                                     Antibiotic resistance   B185             ZP_06660634.1\*                    
  *Enterobacter* sp.                                 pathogen                638              ABP60743.1\*                      transcriptional modulator of MazE/toxin, MazF
  *Shigella dysenteriae*                             pathogen                Sd197            YP_405833.1\*                     toxin ChpB
  *Citrobacter rodentium*                            pathogen                ICC168           YP_003366767.1\*                  Toxin component of the ChpB-ChpS toxin-antitoxin system
  *Vibrio vulnificus*                                pathogen                CECT4999=R99     YP_001393091.1\*                  growth inhibitor
  *Listeria welshimeri* serovar 6b str.              pathogen                SLCC5334         YP_849071.1                       PemK family transcriptional regulator
                                                                             FSL J1-208       ZP_05296226.1\*                   PemK family transcriptional regulator
  *Listeria monocytogenes*                                                   SLCC3954         YP_003464028.1                    transcriptional regulator, PemK family
                                                                             FSL S4-120       ZP_07870171.1                     toxin-antitoxin system, antitoxin component, MazF family
  *Listeria seeligeri* serovar 1/2b str.                                                                                         
  *Listeria marthii*                                                                                                             
  *Listeria grayi*                                   pathogen                DSM 20601        ZP_07054243.1\*                   MazF family toxin-antitoxin system protein
  *Clostridium difficile*                            pathogen                630              YP_001089981.1\*                  putative regulator of cell growth
                                                                             QCD-66c26        ZP_05273557.1                     putative regulator of cell growth
                                                                             CIP 107932       ZP_05323891.1                     putative regulator of cell growth
  *Klebsiella variicola*                             pathogen                At-22            YP_003438577.1\*                  transcriptional modulator of MazE/toxin, MazF pemK; protein PemK
                                                                             1_1\_55          ZP_06548086.1                      
  *Salmonella enterica* subsp. arizonae serovar      pathogen                RSK2980          YP_001573441.1\*                  hypothetical protein SARI_04525
  *Campylobacter showae*                             pathogen                RM3277           ZP_05364729.1                     addiction module antitoxin, RelB/DinJ family
  *Campylobacter concisus*                           pathogen                13826            YP_001466677.1                    addiction module antitoxin
  *Campylobacter jejuni* subsp.                      pathogen                IA3902           ADC28395.1                        prevent-host-death family protein
  *Campylobacter upsaliensis*                        pathogen                JV21             ZP_07894578.1\*                   ChpA/MazF transcriptional modulator
  *Shigella flexneri* 2a str.                        pathogen                301              NP_709188.1\*                     PemK protein
  *Shigella flexneri* 5 str.                                                 8401             YP_690766.1                       growth inhibitor, PemK-like, autoregulated
  *Cronobacter sakazakii*                            pathogen                ATCC BAA-894     YP_001436394.1                    bifunctional antitoxin/transcriptional repressor RelB
  *Lactobacillus coleohominis*                       probiotic               101-4-CHN        ZP_05553821.1\*                   regulatory protein
  *Bacillus megaterium*                              probiotic               QM B1551         YP_003560763.1\*                  endoribonuclease EndoA
                                                                             DSM 319          YP_003595503.1                     
  *Bacillus thuringiensis serovar israelensis*       probiotic               ATCC 35646       ZP_00740711.1\*                   MazF protein
                                                                             KBAB4            YP_001643128.1                    MazF protein
  *Bacillus weihenstephanensis*                                              AH1134           ZP_03233130.1                     PemK family
  *Bacillus cereus*                                                                                                              
  *Coprobacillus sp.*                                probiotic               29_1             ZP_08009764.1\*                   PemK family transcriptional regulator
  *Enterococcus faecalis*                            probiotic               V583             NP_814592.1                       PemK family transcriptional regulator
                                                                             TX0102           EFQ11602.1\*                       
                                                                                                                                Toxin-antitoxin system, toxin compoment, MazF
                                                                             TX2134           ZP_07557645.1\*                    
                                                                                                                                Toxin-antitoxin system, toxin compoment, MazF
                                                                             HH22             ZP_03985009.1                      
                                                                                                                                PemK family transcriptional regulator
  *Lactobacillus plantarum*                          probiotic               WCFS1            NP_786238.1\*                     cell growth regulatory protein
  *Lactobacillus rhamnosus*                          probiotic               LMS2-1           ZP_04441477.1\*                   cell growth regulatory protein
                                                                             Lc 705           YP_003175134.1                    transcriptional modulator of MazE/toxin, MazF
  *Lactobacillus johnsonii*                          probiotic               ATCC 33200       ZP_04007131.1\*                   PemK family growth inhibitor
  *Lactobacillus crispatus*                          probiotics              CTV-05           ZP_07789240.1\*                   ppGpp-regulated growth inhibitor
  *Lactobacillus gasseri*                            probiotic               ATCC 33323       YP_815460.1\*                     toxin-antitoxin system, toxin component, MazF family
                                                                             224-1            ZP_06262236.1                      
                                                                             MV-22            ZP_07711551.1                      
  *Lactobacillus casei*                              probiotic               BL23             YP_001986080.1                    Cell growth regulatory protein
  *Lactobacillus amylovorus*                         probiotic               GRL1118          YP_005854914.1\*                  transcriptional modulator of MazE/toxin MazF
  *Vibrio cholerae*                                  probiotic               1587             ZP_01950611.1\*                   transcriptional modulator of MazE/toxin, MazF
                                                                             NCTC 8457        ZP_01969676.1                      
  *Pediococcus pentosaceus*                          probiotic               ATCC 25745       YP_805020.1\*                     toxin-antitoxin addiction module toxin component MazF (an endoRNAse)
  *Bacillus amyloliquefaciens*                       probiotic               Y2               YP_006327269.1\*                  Endoribonuclease
  *Bacillus pumilus*                                 probiotic               SAFR-032         YP_001485694.1\*                  PemK family growth inhibitor endoribonuclease EndoA
                                                                             ATCC 7061        ZP_03054587.1                      
  *Lactobacillus sakei* subsp. sakai                 probiotic               Sakei 23K        YP_396224.1                       DNA-binding protein PemK family
  *Leuconostoc mesenteroides* subsp. mesenteroides   probiotic               ATCC 8293        YP_819271.1\*                     toxin-antitoxin addiction module toxin component MazF
                                                                             ATCC 19254       ZP_03913232.1                     PemK family growth inhibitor
  *Leuconostoc mesenteroides* subsp. cremoris                                                                                    
  *Enterococcus faecalis*                            probiotic               TX0102           EFQ11602.1\*                      toxin-antitoxin system, toxin component, MazF family
                                                                             TX0031           EFT96737.1                         
  *Bifidobacterium animalis subsp. lactis*           probiotic               HN019            ZP_02964075.1\*                   transcriptional modulator of MazE/toxin, MazF
  *Bifidobacterium bifidum*                          probiotic               NCIMB 41171      ZP_03645723.1                     RelB antitoxin
  *Bifidobacterium longum* subsp. longum             probiotic               JDM301           YP_003660624.1\*                  RelB antitoxin
                                                                             DSM 20213        ZP_06596513.1                     toxin-antitoxin system protein
  *Bifidobacterium breve*                                                                                                        
  *Bifidobacterium bifidum*                          probiotic               S17              YP_003938101.1                    hypothetical protein with RelB antitoxin domain
  *Lactobacillus casei*                              Probiotic               ATCC 334         YP_807723.1                       toxin-antitoxin addiction module toxin component MazF (an endoRNAse)
  *Lactobacillus casei*                              Probiotic               BL23             YP_001988635.1                    Growth inhibitor
  *Lactobacillus paracasei* subsp. paracasei         Probiotic               ATCC 25302       ZP_03963082.1\*                   PemK family transcriptional regulator
  *Lactobacillus casei* str.                         probiotic               Zhang            YP_003789562.1                    toxin-antitoxin addiction module toxin component MazF
  *Lachnospiraceae bacterium*                        probiotic               3_1\_57FAA_CT1   ZP_08609193.1\*                   hypothetical protein HMPREF0994_05199
  *Leuconostoc citreum*                              Probiotic               KM20             YP_001727503.1\*                  growth inhibitor
  *Lactobacillus reuteri*                            probiotic               DSM 20016        YP_001270863.1\*                  transcriptional modulator of MazE/toxin, MazF
                                                                             JCM 1112         YP_001841242.1                    hypothetical protein LAR_0246
                                                                             MM2-3            ZP_03847756.1                     PemK family growth inhibitor
  *Streptococcus* sp. oral taxon 071 str.            probiotic               73H25AP          ZP_07458552.1\*                   ChpA/MazF transcriptional modulator
  *Bacillus selenitireducens*                        probiotic               MLS10            YP_003700699.1\*                  transcriptional modulator of MazE/toxin, MazF
  *Bacillus halodurans*                              probiotic               C-125            NP_244588.1\*                     ppGpp-regulated growth inhibitor (ChpA/MazF)
  *Enterococcus faecium*                             probiotic               DO               ZP_05714797.1\*                   PemK family protein
                                                                             TX0133a04        ZP_07845579.1                     toxin component, MazF family
                                                                             TX0133C          ZP_07850444.1                     toxin component, MazF family

\*: data are presented in Figure [1](#F1){ref-type="fig"}.

Phylogenetic analyses and cluster analysis of MazF/antitoxin protein, a growth inhibitor
----------------------------------------------------------------------------------------

The phylogenetic tree in Figure [1](#F1){ref-type="fig"} displays the phylogentic relationships of many well-recognized genera within *Enterobacteriaceae*, including several important foodborne pathogens such as pathogenic *E. coli*, *Salmonella*, *Listeria*, and *Campylobacter,* as well as some major probiotic strains. To build a phylogenetic tree from the data in Table [2](#T2){ref-type="table"}, the amino acid sequences of all the MazF or growth inhibitor proteins were analyzed using the Geneious software package v5.5.7 with Neighbor-joining (NJ) method by applying ClustalW for sequence alignment (Figure [1](#F1){ref-type="fig"}). Three main clusters (viz., groups 1, 2, and 3) are given in Figure [1](#F1){ref-type="fig"}. At least two representatives of potential probiotic strains are listed for each group, depending on the complexity of groups. In group 1, the potential probiotic, non-pathogenic strains, such as *Lactobacillus amylovorus, Lactobacillus crispatus, Streptococcus, Enterococcus faecium, Enterococcus, Lactobacillus plantarum,* and *Lactobacillus rhamnosus,* are grouped with the foodborne pathogens *E. coli, Vibrio vulnificus, and Vibrio cholerae.* In group 2, the foodborne pathogens *Enterobacter*, *Campylobacter upsaliensis*, *Klebsiella variicola*, *Salmonella enterica*, *Shigella flexneri*, *Shigella dysenteriae*, and *Citrobacter rodentium* were shown to be genetically closer to *Bacillus selenitireducens, Bacillus halodurans, and Enterococcus faecalis* In group 3, some probiotic strains, such as the *Bacillus, Lactobacillus, Leuconostoc,* and the *Bifidobacterium* genera are categorized along with other major foodborne pathogens, such as *Clostridium difficile, Listeria monocytogenes, Listeria grayi,* and an emerging foodborne pathogen *Pediococcus pentosaceus*.

![**Phylogenetic analyses of Enterobacteriaceae based on MazF (toxin), a growth inhibitor.** The NCBI accession numbers are shown after each taxon name.](2045-3701-2-39-1){#F1}

Phylogenetic identification of bacterial toxin MazF protein motifs and the relationship between gene structure and phylogenetic classification
----------------------------------------------------------------------------------------------------------------------------------------------

In Figure [2](#F2){ref-type="fig"}, it is shown that the number of candidate motifs are slightly different in each group, but with a high degree of amino acid sequence variability within conserved "hot spots" between groups 1, 2, and 3. To determine which motifs are the best candidates for the engineered MazF construction (discussed in next section) in each individual group, recent studies \[[@B43]\] suggest that the N-terminal (the first 80 amino acids in Figure [2](#F2){ref-type="fig"}) of the MazF protein are the most suitable motifs. The other motifs in the C-terminal might be referred to as 'incorrect' motifs. There are three criteria for evaluating the remaining motifs as "incorrect and without biological significance", and this is related to: the mean hydrophobicity, identity, and the gene structure. In Figure [2](#F2){ref-type="fig"}, in the analysis for the phylogenetic identification of bacterial Toxin MazF protein motifs, the mean hydrophobicity sequence and identity were computed and compared for each sequence; it is interesting to find that all the compared MazF proteins have a higher degree of mean hydrophobicity, identity, and more conserved gene structure among several conserved amino acid regions, particular in the N-terminal. The selection of potential functional MazF motifs is discussed in the next section. The functional importance of the mean hydrophobicity has also been discussed to involve mRNA and protein degradation and slower translation of mRNA for disordered proteins (<http://employees.csbsju.edu/hjakubowski/classes/ch331/protstructure/olprotfold.html>).

![**ClustalW output (default settings) for the aligned amino acid sequences of MazF.** The pdf images of the alignments were generated using Geneious v5.5.7. Conserved amino acids are highlighted in colors; the numbers (1 to 39) in this Figure correspond to the taxon names in Figure [1](#F1){ref-type="fig"} .](2045-3701-2-39-2){#F2}

Bacterial probiotic cocktail strains
------------------------------------

It is important to note that the benefits of probiotics are strain-specific \[[@B64],[@B65]\]. A commercial product, VSL\#3, developed by Sigma-Tau Pharmaceuticals, Inc., provides a mixture of probiotic bacteria (*B. breve, B. infantis, B. longum, L. acidophilus, L. bulgaricus, L. casei, L. plantarum,* and *Streptococcus thermophilus*) to help protect GI tract integrity \[[@B66]\]. In this study, the bacterial probiotic cocktail strains we propose would be comprised of all representatives of groups 1, 2, and 3 shown in Figure [1](#F1){ref-type="fig"}*.* The principal basis behind the composition of these probiotic cocktail strains is the assumption that a combination of organisms might be more effective than the application of a single strain, which potentially could suppress many foodborne pathogens, such as the *E. coli* and vibros in Group 1, several foodborne pathogens, such as *Enterobacter, Klebsiella variicola, Salmonella enterica, Shigella flexneri, Shigella dysenteriae, Citrobacter rodentium*, and *Campylobacter upsaliensis,* (one of the most common *Campylobacter* strain found in people with diarrhea in Group 2), *Clostridium difficile, Listeria monocytogenes,* and *Listeria grayi,* in Group 3 of Figure [1](#F1){ref-type="fig"}. Table [1](#T1){ref-type="table"} shows an astonishing diversity in the genomic GC-content and genome size among *Lactobacillus* species and their diverse distribution in all groups within Figure [1](#F1){ref-type="fig"}, which indicates a potential to further identify other closely-related *Lactobacillus* species (not listed in Table [1](#T1){ref-type="table"}) into the three previously-described groups*.* The hypothesis underlying our approach is that probiotic strains found within the same group with foodborne pathogens will have a reasonable degree of genetic and molecular phylogenetic compatibility and could bridge a relationship similar to a "symbiosis" of entities, including exchanging toxin/antitoxin molecules among the probiotic and pathogenic strains. *Lactobacillus* species are known to produce antimicrobial substances, including bacteriocins, lactic acid, and hydrogen peroxide. The MazEF toxin component may provide a basis for bacterial growth inhibition within the same group (Figure [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Therefore, this toxin-antitoxin module may have great potential to inhibit the growth of potentially-pathogenic bacteria through a possible competitive exclusion due to selective inhibition \[[@B46]\]. Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} list all possible cocktails of these probiotic strains. In reality, a foodborne outbreak is more likely to be associated with one particular foodborne pathogen in particular foods. For example, there is a low incidence of *Campylobacter* in ground beef and pork, while *Campylobacter* is the major foodborne pathogens associated with poultry, therefore, a single food-borne pathogen with the application of mixed probiotics will be considered initially.

Molecular recombination techniques: construction of genetically engineered synthetic probiotic strains
------------------------------------------------------------------------------------------------------

Figure [3](#F3){ref-type="fig"} details an engineered probiotic strain bearing a recombinant plasmid containing a stress-induced promoter, followed by an in-frame gene fusion accomplished by fusing an appropriate signal peptide, a functional cell death peptide/factor (CDF), an enterokinase (EK) binding site, and a genetically-modified engineered MazF gene*,* which will be constructed and transformed into the probiotic bacteria. In this recombinant probiotic strain, environmental stress, relevant to food environments will trigger gene expression of this fusion protein under an environmental stress-inducible promoter. The signal peptide directs the encoded fusion protein to the extracellular space of the engineered probiotic strains. The signal peptide depleted fusion proteins will be cleaved by a biliary tract enterokinase directly into the digestive system to release the functionally-active CDF and MazF. This event will occur based on the ability of probiotic strains to form stable, non-infectious biofilm-type aggregates, which may attach with other bacteria, including foodborne pathogens, in the urogenital and intestinal tracts \[[@B22]\]. These active species-specific CDF and MazF proteins will bind and pass through "unfriendly" bacterial cell surface barriers into the cytoplasm. These processed CDFs and MazF proteins will selectively inactivate and/or inhibit proteins involved in cell survival and induce the synthesis of more cell death-related proteins with activity against foodborne pathogens, eventually controlling, inhibiting, or inactivating "unfriendly" cells. Although antitoxin MazE could reverse the bacteriocidal effect of the overexpressed MazF, MazE cannot impede the downstream cascade already initiated by MazF at early stages of the MazF-mediated cascade \[[@B42]\].

![**A Schematic representation of the engineered, secreted CDF and*MazF*-mediated cell death during food processing and storage.** SP: promoter, CDF: cell death factor/peptide, EKB: enterokinase binding site.](2045-3701-2-39-3){#F3}

The overall hypothesis for this experiment is graphically presented in Figure [3](#F3){ref-type="fig"}. The engineered MazF gene sequence will be designed based on the genomic sequences of all publically-available foodborne pathogenic strains by using reasoned random gene biosynthesis and/or genuine gene reshuffling to rapidly combine functions and properties of parental genes for the development of improved gene specificity and generality, molecular modeling (transcription factor binding site identification, etc.), and systems biology technologies/tools.

Conclusions
===========

Survival of foodborne pathogens in cultures or in animal GI tracts may be very genus- or species-specific. Data presented in this paper can be explored to develop effective intervention strategies applied directly during food processing and preparation, as well as in the animal feed supply, which may lead to an overall reduction in use of antibiotic growth promoters (AGP) throughout the world. Recent research in molecular biology and genomics has provided potential applications of probiotic strains as dietary supplements, which could replace AGP in animal diets or as biotherapeutic agents in cases of antibiotic-associated diarrhea in travelers and in childhood diarrhea and other bacterial gastrointestinal illnesses. Experiments relating to this potential probiotic application may reveal a further greater range of potential benefits. For many of these potential benefits, current research is limited, and only preliminary results are available. All effects can only be attributed to the individual strain(s) tested. Testing of a specific supplement may not be extrapolated to benefits from any other strain of the same species, and testing results do not imply that comparable benefits will be imparted from other LAB (or other probiotics). In this study, we have computationally explored several potential intervention strategies to control foodborne pathogens, either by using a cocktail of probiotic strains or an engineered probiotic strain.

The inhibition of pathogens by probiotic strains is mainly due to the production of antibacterial peptides \[[@B67]\], the release of short-chain fatty acids, or reduction of the pH within the lumen \[[@B68],[@B69]\] by the production of organic acids or by decreasing pathogen adherence to intestinal epithelial cells \[[@B70]\]. Therefore, the benefits of probiotics could be very strain- or species-specific, and probiotic strains may rely on different mechanisms to suppress growth, attachment, or other metabolic processes, inherent to pathogenic bacteria. Moreover, the optimal effects of probiotic strains may involve the simultaneous use of more than one strain. Our contention in this paper is not experimental proof but, rather, a clear scientifically-backed hypothesis in the form of a detailed accompanying method that multi-probiotic strain composites with diverse genetic backgrounds may complement \[[@B71]\] one another as vectors of competitive exclusion and, therefore, could maximize the potential to inhibit an array of common foodborne pathogens \[[@B72]\] in the gastrointestinal tract of humans or livestock, as well as in foods and animal feed.

The use of probiotic bacteria with the ability to produce CDFs and engineered MazF to selectively inactivate pathogens is a novel approach to controlling pathogens in foods, and possibly treating human infections. A number of studies suggest that this project could have practical significance and be a potentially new approach for the development of novel and cost-effective food safety intervention technologies for the control of foodborne pathogens and improving public health \[[@B73]-[@B75]\].

The approaches described above represent a first attempt to describe a systematic approach or method to test the hypothesis that "friendly" bacteria can be used to inactivate or inhibit pathogens in food based on expression of MazF. There are many specific cell death factors that may be associated with bacterial programmed cell death and multi-cellular behavior mechanisms in foodborne pathogens. Through computational modeling, remodeling, genetic recombination, or further gene reshuffling, and exploring experimental approaches, it may be possible to evaluate and elucidate more effective CDFs and MazF to be used for controlling foodborne pathogens, which will ultimately result in a reduction in the use of antimicrobial compounds in humans and animals, as well as during food processing and storage.

Materials and methods
=====================

Genomic sequences
-----------------

All of the genome and gene sequences examined in this study (Table [1](#T1){ref-type="table"} &[2](#T2){ref-type="table"}) are available in GenBank (<http://www.ncbi.nlm.nih.gov/genbank/GenbankOverview.html>).

Identification and analysis of bacterial toxin-antitoxin modules, MazE/MazF
---------------------------------------------------------------------------

The prediction accuracy of the best chromosomal-encoded MazF orthologs among relatively distinct genome strains is critical for the performance of molecular phylogenetic analysis. We used a sequential BLAST workflow based on pairwise comparison by applying either an *E. coli* programmed cell death toxin MazF (Genbank accession: ZP_06660634.1), an endoribonuclease MazF, a MazF protein from *Vibrio cholerae* (ZP_01950611.1), or a PemK family transcriptional regulator protein (ZP_05296226.1) from *Listeria monocytogenes* to perform a BLASTP homology search of these combined protein sequences with all 75 publically available foodborne pathogen and probiotic strain genomic sequences (presented in Table [1](#T1){ref-type="table"}) publically available databases such as NCBI and Uniprot database (<http://www.uniprot.org/>). BLAST search results were used to list MazF or MazF-like proteins from 75 different strains being represented as 39 different species (Table [2](#T2){ref-type="table"}).

Phylogenetic analysis and computational identification of phylogenetic motifs of the MazF protein
-------------------------------------------------------------------------------------------------

In order to identify potential functional motifs of MazF proteins, phylogentic analyses of MazF proteins were conducted by applying the embedded multiple sequence alignment ClustalW program in the Geneious software package v 5.5.7 \[[@B76],[@B77]\] with the Neighbor Joining method. ClustalW output for the aligned amino acid sequences and the pdf images of the alignments were generated using the Geneious software package v 5.5.7.
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